相似文献
1
Minimizing policy-biased appraisals of the evidence on cannabis and psychosis.
Front Psychiatry. 2023 Jan 9;13:1047860. doi: 10.3389/fpsyt.2022.1047860. eCollection 2022.
2
Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies.
Int J Drug Policy. 2010 Jan;21(1):10-9. doi: 10.1016/j.drugpo.2009.09.001. Epub 2009 Sep 26.
3
What are the policy implications of the evidence on cannabis and psychosis?
Can J Psychiatry. 2006 Aug;51(9):566-74. doi: 10.1177/070674370605100904.
4
[Cannabis and psychosis: search of a causal link through a critical and systematic review].
Encephale. 2009 Sep;35(4):377-85. doi: 10.1016/j.encep.2008.02.012. Epub 2008 Jul 9.
5
Causal association between cannabis and psychosis: examination of the evidence.
Br J Psychiatry. 2004 Feb;184:110-7. doi: 10.1192/bjp.184.2.110.
6
Cannabis use and psychosis.
Drug Alcohol Rev. 1998 Dec;17(4):433-44. doi: 10.1080/09595239800187271.
7
Patient's perceptions of the cannabis-psychosis link--a systematic review.
Curr Pharm Des. 2012;18(32):5105-12. doi: 10.2174/138161212802884645.
8
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis.
World J Biol Psychiatry. 2022 Dec;23(10):719-742. doi: 10.1080/15622975.2022.2038797. Epub 2022 Mar 22.
9
Cannabis and Psychosis: a Critical Overview of the Relationship.
Curr Psychiatry Rep. 2016 Feb;18(2):12. doi: 10.1007/s11920-015-0657-y.
10
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.
World Psychiatry. 2016 Oct;15(3):195-204. doi: 10.1002/wps.20341.
本文引用的文献
1
The 1964 US Surgeon General's report on smoking and health.
Addiction. 2022 Dec;117(12):3170-3175. doi: 10.1111/add.16007. Epub 2022 Jul 26.
2
The costs and benefits of cannabis control policies
.
Dialogues Clin Neurosci. 2020 Sep;22(3):281-287. doi: 10.31887/DCNS.2020.22.3/whall.
3
Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia.
JAMA Psychiatry. 2021 May 1;78(5):467-468. doi: 10.1001/jamapsychiatry.2020.3564.
4
Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?
JAMA Psychiatry. 2020 Aug 1;77(8):777-778. doi: 10.1001/jamapsychiatry.2020.0339.
5
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis.
Lancet Psychiatry. 2020 Apr;7(4):344-353. doi: 10.1016/S2215-0366(20)30074-2. Epub 2020 Mar 17.
6
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.
Lancet. 2019 Oct 26;394(10208):1580-1590. doi: 10.1016/S0140-6736(19)31789-1. Epub 2019 Oct 23.
7
Cannabis use and psychosis: a review of reviews.
Eur Arch Psychiatry Clin Neurosci. 2020 Jun;270(4):403-412. doi: 10.1007/s00406-019-01068-z. Epub 2019 Sep 28.
8
Phenomenology and Course of Alcoholic Hallucinosis.
J Dual Diagn. 2019 Jul-Sep;15(3):172-176. doi: 10.1080/15504263.2019.1619008. Epub 2019 Jun 4.
9
Six policy lessons relevant to cannabis legalization.
Am J Drug Alcohol Abuse. 2019;45(6):698-706. doi: 10.1080/00952990.2019.1569669. Epub 2019 Mar 14.
10
The Effects of Tobacco Smoking, and Prenatal Tobacco Smoke Exposure, on Risk of Schizophrenia: A Systematic Review and Meta-Analysis.
Nicotine Tob Res. 2020 Jan 27;22(1):3-10. doi: 10.1093/ntr/nty160.
Zotero 插件